tetrabenazine has been researched along with Nerve Degeneration in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Scott, PJ; Studenski, S | 1 |
| Hersch, SM | 1 |
| Carey, JE; DaSilva, JN; Kilbourn, MR; Pisani, TJ; Sherman, PS | 1 |
| Moy, LY; Sonsalla, PK; Zeevalk, GD | 1 |
| German, DC; Lane, K; Liang, CL; Manaye, KF; Sonsalla, PK | 1 |
1 review(s) available for tetrabenazine and Nerve Degeneration
| Article | Year |
|---|---|
Huntington's disease: prospects for neuroprotective therapy 10 years after the discovery of the causative genetic mutation.
Topics: Amantadine; Anti-Dyskinesia Agents; Antiparkinson Agents; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Humans; Huntingtin Protein; Huntington Disease; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Point Mutation; Riluzole; Tetrabenazine; Time Factors | 2003 |
4 other study(ies) available for tetrabenazine and Nerve Degeneration
| Article | Year |
|---|---|
Gait speed in Parkinson disease correlates with cholinergic degeneration.
Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Analysis of Variance; Carbon Isotopes; Cerebral Cortex; Cognition Disorders; Cross-Sectional Studies; Dioxolanes; Female; Gait Disorders, Neurologic; Humans; Male; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2013 |
Characterization of [11C]tetrabenazine as an in vivo radioligand for the vesicular monoamine transporter.
Topics: Absorption; Animals; Binding, Competitive; Biogenic Monoamines; Biological Transport; Carbon Radioisotopes; Female; Humans; Male; Membrane Glycoproteins; Mice; Nerve Degeneration; Radiation Dosage; Radioligand Assay; Rats; Rats, Sprague-Dawley; Tetrabenazine; Tissue Distribution | 1994 |
Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures.
Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Biological Transport; Carbon Radioisotopes; Cells, Cultured; Corpus Striatum; Dopamine; Energy Metabolism; Free Radicals; gamma-Aminobutyric Acid; Lactic Acid; Male; Malonates; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Microdialysis; Nerve Degeneration; Neurons; Neuropeptides; Parkinson Disease; Presynaptic Terminals; Synaptic Vesicles; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins | 2000 |
Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Cell Count; Drug Synergism; Locus Coeruleus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Mice; Nerve Degeneration; Neurons; Neuropeptides; Norepinephrine; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2000 |